HOOKIPA PHARMA INC
COM · CUSIP 43906K100
1
institutional holders
-39 vs Q2 2024
551.7k
shares reported held*
$7.2mreported value*
0 new
0 added
1 reduced
38 sold out
net sold ≈ $344.6m (-26.4m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $13.03.
Trends to Q3 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 54 |
| Q4 2022 | 55 |
| Q1 2023 | 46 |
| Q2 2023 | 54 |
| Q3 2023 | 46 |
| Q4 2023 | 42 |
| Q1 2024 | 48 |
| Q2 2024 | 40 |
| Q3 2024 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 22 | 23 |
| Q1 2023 | 10 | 25 |
| Q2 2023 | 29 | 17 |
| Q3 2023 | 13 | 27 |
| Q4 2023 | 15 | 22 |
| Q1 2024 | 20 | 9 |
| Q2 2024 | 22 | 21 |
| Q3 2024 | 0 | 39 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2023 | $51.5k | $17.6k | 0.34 |
| Q1 2024 | $107.3k | $46.5k | 0.43 |
| Q2 2024 | $88.7k | $40.4k | 0.46 |
| Q3 2024 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| EcoR1 Capital, LLC | Sold out | -5.7m |
| Artal Group S.A. | Sold out | -5.7m |
| Knoll Capital Management, LLC | Reduced | -5.0m |
| FMR LLC | Sold out | -3.4m |
| VANGUARD GROUP INC | Sold out | -2.1m |
| Redmile Group, LLC | Sold out | -1.1m |
| ACADIAN ASSET MANAGEMENT LLC | Sold out | -991.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -707.8k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -302.2k |
| MORGAN STANLEY | Sold out | -235.9k |
Holders, Q3 2024
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLC 3.33% of their portfolio | 551.7k $7.2m | Reduced -5.0m |